SPECTRAL AI, INC. Sale of Stock, Consideration Received on Transaction
SPECTRAL AI, INC. (MDAI) had Sale of Stock, Consideration Received on Transaction of $30.00 million as of 2024-03-20, per its 10-K filed 2025-03-31.
Financial Statements › Notes › Equity
us-gaap:SaleOfStockConsiderationReceivedOnTransaction · last filed 2025-03-31
- 2024-03-20: Sale of Stock, Consideration Received on Transaction $30.00M.
- 2023-09-30: Sale of Stock, Consideration Received on Transaction 9 month $1.00M.
- 2021-09-30: Sale of Stock, Consideration Received on Transaction 9 month $3.10B.
| Period end | Sale of Stock, Consideration Received on Transaction | Sale of Stock, Consideration Received on Transaction 9 month |
|---|---|---|
| 2024-03-20 | $30.00M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $1.00M 10-Q · filed 2023-11-14 | |
| 2021-09-30 | $3.10B 10-Q · filed 2021-11-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |